Jeffrey A Moscow

10PUBLICATIONS
192CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 21, 2025
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial).

Husam A Alqaisi, David E Cohn, Jing-Yi Chern

|Jul 31, 2024
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis.

Brian S White, Xing Yi Woo, Soner Koc

|Jul 10, 2024
Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A.

Scott N Gettinger, Zihe Song, Karen L Reckamp

|Apr 19, 2024
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations.

Funda Meric-Bernstam, Michael W Lloyd, Soner Koc

|Dec 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma.

Yige Wu, Siqi Chen, Xiaolu Yang

|Aug 02, 2023
The New NCI Precision Medicine Trials.

Lyndsay N Harris, Charles D Blanke, Harry P Erba

Pageof 2

Frequent Collaborators

5 joint publications

Funda Meric-Bernstam

5 joint publications

Jeffrey H Chuang

5 joint publications

Alana Welm

5 joint publications

Yvonne A Evrard